TY - JOUR
T1 - Review article
T2 - The medical management of Crohn's disease
AU - Elton, E.
AU - Hanauer, S. B.
PY - 1996
Y1 - 1996
N2 - The choice of medical therapies for Crohn's disease continues to grow, Although our understanding of the mechanisms of the disease is incomplete, increasing knowledge of the pathogenesis of inflammation in general and Crohn's disease in particular allows targeting of therapies at various points in the immunoinflammatory cascade. In addition, the,division of Crohn's disease into subtypes by location, aggressiveness, and the presence or absence of perianal and fistulizing disease allows the tailoring of medical therapy to the individual patient. For those patients with moderate to severe symptoms or frequent flares of disease activity, and those who have required surgical resection, maintenance therapy can substantially reduce the rate of recurrence. Despite these advances, available medical therapies for Crohn's disease remain imperfect, as evidenced by their sometimes substantial toxicities and the continued frequent need for surgery.
AB - The choice of medical therapies for Crohn's disease continues to grow, Although our understanding of the mechanisms of the disease is incomplete, increasing knowledge of the pathogenesis of inflammation in general and Crohn's disease in particular allows targeting of therapies at various points in the immunoinflammatory cascade. In addition, the,division of Crohn's disease into subtypes by location, aggressiveness, and the presence or absence of perianal and fistulizing disease allows the tailoring of medical therapy to the individual patient. For those patients with moderate to severe symptoms or frequent flares of disease activity, and those who have required surgical resection, maintenance therapy can substantially reduce the rate of recurrence. Despite these advances, available medical therapies for Crohn's disease remain imperfect, as evidenced by their sometimes substantial toxicities and the continued frequent need for surgery.
UR - http://www.scopus.com/inward/record.url?scp=0030064095&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0030064095&partnerID=8YFLogxK
U2 - 10.1111/j.1365-2036.1996.tb00173.x
DO - 10.1111/j.1365-2036.1996.tb00173.x
M3 - Review article
C2 - 8871440
AN - SCOPUS:0030064095
SN - 0269-2813
VL - 10
SP - 1
EP - 22
JO - Alimentary Pharmacology and Therapeutics
JF - Alimentary Pharmacology and Therapeutics
IS - 1
ER -